Conditions: Hepatic Insufficiency Healthy
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 36
Healthy volunteers: yes

Brief summary:
The main objective of this study is to assess the effect of mild, moderate and severe hepatic impairment on the pharmacokinetics, safety and tolerability of BI 10773 following oral administration of BI 10773 as a single dose.

Detailed description:

Arms:
arm 1: 50 mg single dose

Interventions: intervention 1: BI 10773
Intervention descriptions: intervention 1: 2 tablets BI 10773 25 mg single dose

Protocol document: